title: Reduced FAS transcription in clones of U937 cells that have acquired resistance to Fas-induced apoptosis.
abstract: Susceptibility to cell death is a prerequisite for the elimination of tumour cells by cytotoxic immune cells, chemotherapy or irradiation. Activation of the death receptor Fas is critical for the regulation of immune cell homeostasis and efficient killing of tumour cells by apoptosis. To define the molecular changes that occur during selection for insensitivity to Fas-induced apoptosis, a resistant variant of the U937 cell line was established. Individual resistant clones were isolated and characterized. The most frequently observed defect in the resistant cells was reduced Fas expression, which correlated with decreased FAS transcription. Clones with such reduced Fas expression also displayed partial cross-resistance to tumour necrosis factor-alpha stimulation, but the mRNA expression of tumour necrosis factor receptors was not decreased. Reintroduction of Fas conferred susceptibility to Fas but not to tumour necrosis factor-alpha stimulation, suggesting that several alterations could be present in the clones. The reduced Fas expression could not be explained by mutations in the FAS coding sequence or promoter region, or by silencing through methylations. Protein kinase B and extracellular signal-regulated kinase, components of signalling pathways downstream of Ras, were shown to be activated in some of the resistant clones, but none of the three RAS genes was mutated, and experiments using chemical inhibitors could not establish that the activation of these proteins was the cause of Fas resistance as described in other systems. Taken together, the data illustrate that Fas resistance can be caused by reduced Fas expression, which is a result of an unidentified mode of regulation.
authors.affiliation: Department of Molecular Biology, Umeå University, Sweden. jeanette.blomberg@molbiol.umu.se
authors.forename: Jeanette
authors.initials: J
authors.lastname: Blomberg
authors.forename: Kristina
authors.initials: K
authors.lastname: Ruuth
authors.forename: Maria
authors.initials: M
authors.lastname: Jacobsson
authors.forename: Andreas
authors.initials: A
authors.lastname: Höglund
authors.forename: Jonas A
authors.initials: JA
authors.lastname: Nilsson
authors.forename: Erik
authors.initials: E
authors.lastname: Lundgren
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D002469:Cell Separation / Q000379:methods*; D015536:Down-Regulation; D006801:Humans; D020935:MAP Kinase Signaling System; D008745:Methylation; D012333:RNA, Messenger / Q000235:genetics; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism; D014158:Transcription, Genetic / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D020298:U937 Cells; D019014:fas Receptor / Q000235:genetics / Q000378:metabolism*
chemical_list: D012333:RNA, Messenger; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor